Formulation for a protein pharmaceutical without added human serum albumin (HSA)

Details for Australian Patent Application No. 2004257391 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Frevert, Jurgen

Agent Wrays

Pub. Number AU-B-2004257391

PCT Pub. Number WO2005/007185

Priority 103 33 317.7 22.07.03 DE

Filing date 22 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 11 February 2010

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/007185 Priority application(s): WO2005/007185

14 January 2010 Assignment before Grant

  Biotecon Therapeutics GmbH The application has been assigned to Merz Pharma GmbH & Co. KGaA Assignments before Grant, Section 113

11 February 2010 Application Accepted

  Published as AU-B-2004257391

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257394-Arrangement comprising a cervical prosthesis and an insertion instrument

2004257388-Method for operation of a laser